CooperVision introduces new President, Americas Steven Robins

News
Article

Robins has worked in the healthcare industry for 3 decades in several high-profile corporate leadership and consulting roles.

Steven Robins Image credit: CooperVision

Steven Robins Image credit: CooperVision

CooperVision has appointed a new president for its Americas team. Steven Robins, most recently the managing partner and principal for The New England Consulting Group, has worked in the healthcare industry for 3 decades, with several high-profile corporate leadership and consulting roles under his belt, according to a news release.

“Since my first foray into ocular health almost 20 years ago, I have known that there’s something special about this industry, shown by the way its professionals and products come together to make the world better for millions of people every day. There are big opportunities in vision care, and CooperVision is a clear leader in several. It’s a privilege to join the company that has its sights set on becoming an even greater part of people’s lives through remarkable innovations and partnerships,” said Robins in the release.

In his work with The New England Consulting Group, Robins worked with a variety of Fortune 500 organizations in the medical device, pharmaceutical, and OTC/vitamin sectors. He also worked with CooperVision in multiple strategic engagements, including the US introduction of MiSight 1 day contact lens for myopia control. Previously, he also served as chief marketing officer and president of North American Vision Care for Bausch + Lomb, general manager of Johnson & Johnson’s Consumer Healthcare business in Canada, and as the group marketing director for Pfizer Consumer Healthcare.1

“Steven has been working with CooperVision for a number of years on strategic, priority projects including our MiSight® 1 day contact lenses,” said Debbie Olive, chief commercial officer for CooperVision, in the release. “I am impressed with his strategic thinking as well as his passion for the industry and our customers. He is a charismatic, engaging leader who undoubtedly will drive positive impacts throughout our Americas business.”

Robins holds a Bachelor of Arts from Bates College and participated in the Pfizer Global Leadership Program with Harvard University, the release stated. In his new position with CooperVision, he plans to relocate to Rochester, New York.1

Reference:
  1. CooperVision names Steven Robins as President, Americas. News release. CooperVision. January 27, 2025. Accessed January 27, 2025. https://coopervision.com/our-company/news-center/press-release/coopervision-names-steven-robins-president-americas

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.